Cryoglobulinemic Vasculitis Stemming from Delayed Recognition of Rheumatoid Arthritis

Vasculite Crioglobulinémica como Apresentação Inicial de Artrite Reumatoide

Autores

  • Ana Carolina Monteiro Serviço de Medicina Interna, Unidade Local de Saúde Amadora / Sintra, Amadora, Portugal https://orcid.org/0000-0002-8458-8985
  • Ivone Valadão Unidade de Imunologia Clínica, Unidade Local de Saúde de Santo António, Porto, Portugal
  • Tomás França de Santana Serviço de Radiologia, Hospital CUF Tejo, Lisboa, Portugal
  • Tomás Fonseca Unidade de Imunologia Clínica, Unidade Local de Saúde de Santo António, Porto, Portugal

DOI:

https://doi.org/10.60591/crspmi.277

Palavras-chave:

Arthritis, Rheumatoid, Cryoglobulinemia, Peripheral Nervous System Diseases, Systemic Vasculitis, Vasculitis, Leukocytoclastic, Cutaneous

Resumo

Cryoglobulinemic vasculitis (CV) is an immunocomplex-
-mediated condition with multi-organ involvement and a heterogeneous clinical presentation. CV has been documented in patients with rheumatoid arthritis (RA) but its incidence is nowadays rare due to the early diagnosis and proper therapeutic management of RA, including the emergence of biologic disease-modifying antirheumatic drug therapy.

We report a case of a 61-year-old woman who presented
with a 5-day history of violaceous macular lesions on both
lower limbs, decreased left lower limb sensitivity and inability to walk. She also reported a 17-year history of chronic symmetrical additive polyarthralgia of metacarpophalangeal joints, which was accompanied by synovitis and deformities of these joints.

Blood analysis showed normocytic anemia, elevated
acute phase reactants, elevated rheumatoid factor and anti-
-cyclic citrullinated peptide antibody, reduced complement
component 4 and elevated cryoglobulins with type III mixed
cryoglobulinemia pattern. Skin biopsy revealed cutaneous
necrotizing vasculitis / neutrophilic venulitis. Systemic corticosteroid therapy and rituximab were started with clinical and analytical improvement.

This long-standing untreated case of seropositive RA
presenting with CV demonstrates that, despite being a rare
complication of RA, CV can be its initial presentation. A high
index of clinical suspicion is the key to an early diagnosis,
and prompt treatment institution is crucial to minimize morbidity and mortality.

 

 

 

Downloads

Não há dados estatísticos.

Referências

Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, et al. Cryoglobulinaemia. Nat Rev Dis Primers. 2018;4:11. doi: 10.1038/s41572-018-0009-4.

Desbois AC, Cacoub P, Saadoun D. Cryoglobulinemia: An update in 2019. Joint Bone Spine. 2019;86:707-13. doi: 10.1016/j.jbspin.2019.01.016

Silva F, Pinto C, Barbosa A, Borges T, Dias C, Almeida J. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019;105:102313. doi: 10.1016/j.jaut.2019.102313

Kishore S, Maher L, Majithia V. Rheumatoid vasculitis: a diminishing yet devastating menace. Cur Rheumatol Rep. 2017;19:39. doi: 10.1007/s11926-017-0667-3

Núñez-Conde A, Rodríguez-Pintó I, Alba-Garibay DA, Álvarez-Abella A, Jerez-Lienas A, Llargués O, et al. Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice. Vessel Plus. 2023. doi: 10.20517/2574-1209.2023.105

Dammacco F, Lauletta G, Vacca A. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin Exp Med. 2022;23:255-72. doi: 10.1007/s10238-022-00808-1

Clinical presentation: large, erythematous-violaceous macules, localized on the posterior surface of both legs.

Downloads

Publicado

09-12-2024

Como Citar

Monteiro, A. C., Valadão , I., França de Santana, T., & Fonseca, T. (2024). Cryoglobulinemic Vasculitis Stemming from Delayed Recognition of Rheumatoid Arthritis: Vasculite Crioglobulinémica como Apresentação Inicial de Artrite Reumatoide. SPMI Case Reports, 2(4), 153–58. https://doi.org/10.60591/crspmi.277